Transcription of FDA Public Health Notification: Serious Complications ...
{{id}} {{{paragraph}}}
US FDA/CDRH: Public Health notification : Serious Complications associated with transvaginal Page 1 of 3. FDA Home Page | CDRH Home Page | Search | A-Z Index FDA > CDRH > Medical Device Safety > Public Health Notifications > FDA Public Health notification : Serious Complications associated with transvaginal placement of Surgical Mesh in repair of Pelvic Organ prolapse and Stress Urinary Incontinence FDA Public Health notification : Serious Complications associated with transvaginal placement of Surgical Mesh in repair of Pelvic Organ prolapse and Stress Urinary Incontinence Issued: October 20, 2008. Dear Healthcare Practitioner: This is to alert you to Complications associated with transvaginal placement of surgical mesh to treat Pelvic Organ prolapse (POP) and Stress Urinary Incontinence (SUI).
FDA > CDRH > Medical Device Safety > Public Health Notifications > FDA Public Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of Pelvic Organ Prolapse and Stress Urinary Incontinence
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}